Definitive Healthcare Corp. (NASDAQ:DH) Insider Sells $211,500.00 in Stock

Definitive Healthcare Corp. (NASDAQ:DH) insider William Moschella sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares in the company, valued at $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Definitive Healthcare Trading Down 2.1 %

Shares of NASDAQ DH traded down $0.10 during trading on Thursday, reaching $4.66. The company had a trading volume of 16,479 shares, compared to its average volume of 730,123. The business’s 50-day moving average is $4.38 and its 200 day moving average is $4.77. Definitive Healthcare Corp. has a 12-month low of $3.19 and a 12-month high of $10.62. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of DH. Point72 DIFC Ltd increased its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock worth $42,000 after buying an additional 8,215 shares in the last quarter. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare during the third quarter valued at approximately $55,000. Bleakley Financial Group LLC bought a new position in Definitive Healthcare during the third quarter valued at approximately $74,000. Glenmede Trust Co. NA lifted its position in Definitive Healthcare by 41.1% during the third quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock valued at $82,000 after purchasing an additional 5,362 shares during the period. Finally, SG Americas Securities LLC purchased a new stake in Definitive Healthcare in the third quarter worth approximately $84,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have commented on DH. Robert W. Baird decreased their price objective on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. Barclays reduced their target price on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Finally, BTIG Research started coverage on Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 price target on the stock. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, Definitive Healthcare presently has a consensus rating of “Hold” and a consensus target price of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.